Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSEARCA:EMC TSE:IMV NYSEAMERICAN:MTNB TSE:RVX On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeEMCGlobal X Emerging Markets Great Consumer ETF$37.05+0.3%$33.20$27.39▼$37.56$65.58M0.8213,966 shs5,856 shsIMVIMVC$0.00C$0.62▼C$15.90C$13.12M1.5256,822 shs15,761 shsMTNBMatinas Biopharma$0.57+1.4%$0.58$0.48▼$3.09$3.61M1.6134,778 shs11,813 shsRVXResverlogixC$0.10+5.3%C$0.11C$0.04▼C$0.30C$31.62M0.71830831,637 shs6,000 shs7 Stocks That Could Be Bigger Than Tesla, Nvidia, and GoogleLooking for the next FAANG stock before everyone has heard about it? Click the link to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceEMCGlobal X Emerging Markets Great Consumer ETF+0.30%+0.95%+9.39%+9.88%+31.71%IMVIMV0.00%0.00%0.00%0.00%0.00%MTNBMatinas Biopharma+1.44%-11.30%+8.15%-3.05%-16.81%RVXResverlogix+5.26%0.00%-4.76%+5.26%+150.00%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeEMCGlobal X Emerging Markets Great Consumer ETF$37.05+0.3%$33.20$27.39▼$37.56$65.58M0.8213,966 shs5,856 shsIMVIMVC$0.00C$0.62▼C$15.90C$13.12M1.5256,822 shs15,761 shsMTNBMatinas Biopharma$0.57+1.4%$0.58$0.48▼$3.09$3.61M1.6134,778 shs11,813 shsRVXResverlogixC$0.10+5.3%C$0.11C$0.04▼C$0.30C$31.62M0.71830831,637 shs6,000 shs7 Stocks That Could Be Bigger Than Tesla, Nvidia, and GoogleLooking for the next FAANG stock before everyone has heard about it? Click the link to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceEMCGlobal X Emerging Markets Great Consumer ETF+0.30%+0.95%+9.39%+9.88%+31.71%IMVIMV0.00%0.00%0.00%0.00%0.00%MTNBMatinas Biopharma+1.44%-11.30%+8.15%-3.05%-16.81%RVXResverlogix+5.26%0.00%-4.76%+5.26%+150.00%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceEMCGlobal X Emerging Markets Great Consumer ETF 2.74Moderate Buy$37.05N/AIMVIMV 0.00N/AN/AN/AMTNBMatinas Biopharma 0.00N/AN/AN/ARVXResverlogix 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownCompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookEMCGlobal X Emerging Markets Great Consumer ETFN/AN/AN/AN/AN/AN/AIMVIMVC$23K0.00N/A1.61C($0.69) per share0.00MTNBMatinas Biopharma$1.10M3.33N/AN/A$0.47 per share1.22RVXResverlogixN/AN/AC$0.00 per share132.50C($0.31) per shareN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateEMCGlobal X Emerging Markets Great Consumer ETFN/A$1.0734.63N/AN/AN/AN/AN/AN/AIMVIMV-C$37.99M-C$6.11N/AN/AN/AN/A-508.58%-61.78%N/AMTNBMatinas Biopharma-$10.35M-$3.89N/AN/AN/AN/A-193.02%-124.09%N/ARVXResverlogix-C$2.81M-C$0.03N/AN/AN/AN/A8.40%-34.90%N/ALatest RVX, EMC, MTNB, and IMV EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/8/2026Q1 2026MTNBMatinas BiopharmaN/A-$0.30N/A-$0.30N/AN/A3/31/2026Q4 2025MTNBMatinas BiopharmaN/A-$0.26N/A-$0.26N/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthEMCGlobal X Emerging Markets Great Consumer ETF$0.240.65%N/A22.43%N/AIMVIMVN/AN/AN/AN/AN/AMTNBMatinas BiopharmaN/AN/AN/AN/AN/ARVXResverlogixN/A7.02%N/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioEMCGlobal X Emerging Markets Great Consumer ETFN/AN/AN/AIMVIMV1,231.012.932.32MTNBMatinas BiopharmaN/A1.322.79RVXResverlogix-81.940.040.04Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipEMCGlobal X Emerging Markets Great Consumer ETF79.86%IMVIMV20.37%MTNBMatinas Biopharma11.77%RVXResverlogix0.01%Insider OwnershipCompanyInsider OwnershipEMCGlobal X Emerging Markets Great Consumer ETF0.40%IMVIMV0.41%MTNBMatinas Biopharma4.60%RVXResverlogix42.66%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableEMCGlobal X Emerging Markets Great Consumer ETFN/A1.77 millionN/ANot OptionableIMVIMV2011.71 millionN/ANot OptionableMTNBMatinas Biopharma306.41 million6.11 millionN/ARVXResverlogix19316.17 millionN/ANot OptionableRVX, EMC, MTNB, and IMV HeadlinesRecent News About These CompaniesResverlogix (TSE:RVX) Stock Crosses Below 50 Day Moving Average - Here's What HappenedMay 13 at 4:59 AM | americanbankingnews.comResverlogix Corp.: Resverlogix Announces One-Year Extension of DebentureMay 11, 2026 | finanznachrichten.deResverlogix Corp. Announces Filing of Annual Filings and Revocation of MCTOApril 16, 2026 | finance.yahoo.comResverlogix Clears Cease Trade Order After Filing 2025 Annual ResultsApril 16, 2026 | tipranks.comResverlogix Hit With Management Cease Trade Order Over Late Annual FilingsApril 2, 2026 | tipranks.comResverlogix Corp.: Resverlogix Corp. Announces Issuance of MCTO by ASCApril 2, 2026 | finanznachrichten.deResverlogix Corp. Announces Issuance of MCTO by ASCApril 2, 2026 | finance.yahoo.comResverlogix Corp. Provides Bi-Weekly MCTO Status UpdateApril 1, 2026 | finance.yahoo.comResverlogix Faces Filing Delay as Alberta Regulator Reviews Cease Trade RequestMarch 31, 2026 | tipranks.comResverlogix Announces Delay in Filing of Annual Financial Statements, AIF, and MD&AMarch 18, 2026 | cantechletter.comCResverlogix Closes $2.8 Million Shares-for-Interest Private PlacementFebruary 18, 2026 | finance.yahoo.comResverlogix Converts $2.8 Million Interest into Equity in Insider-led FinancingFebruary 18, 2026 | tipranks.comResverlogix Strengthens Board with Appointment of Legal Expert Bradley GlassNovember 19, 2025 | msn.comResverlogix Corp.: Resverlogix Appoints Bradley Glass to Board of DirectorsNovember 18, 2025 | finanznachrichten.deResverlogix Appoints Bradley Glass to Board of DirectorsNovember 18, 2025 | finance.yahoo.comResverlogix Corp. Advances Long-COVID Treatment Study with ApabetaloneOctober 27, 2025 | tipranks.comResverlogix Corp.: Resverlogix Announces Voting Results from the 2025 Meeting of ShareholdersJune 30, 2025 | finanznachrichten.deResverlogix Announces Voting Results from the 2025 Meeting of ShareholdersJune 30, 2025 | finance.yahoo.comNew beanless 'coffee' emerges but does it taste any good?September 17, 2024 | bbc.comBNumerous Independent Groups Presented Data that Supports Apabetalone’s Potential Cardioprotective Benefits at European Society of Cardiology Congress 2024September 3, 2024 | msn.comMedia Sentiment Over TimeRVX, EMC, MTNB, and IMV Company DescriptionsGlobal X Emerging Markets Great Consumer ETF NYSEARCA:EMC$37.05 +0.11 (+0.30%) As of 05/14/2026 04:10 PM EasternThe Global X Emerging Markets Great Consumer ETF (EMC) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund is an actively managed fund that invests in companies across multiple sectors that are positioned to benefit from the increasing consumption and growing purchasing power of consumers from the emerging markets. EMC was launched on Sep 24, 2010 and is managed by Global X.IMV TSE:IMVIMV Inc. operates as a clinical-stage immuno-oncology company. The company develops a portfolio of therapies based on DPX its immune-educating technology platform for treatment of solid and hematological cancers. The company's lead drug candidate includes maveropepimut-S, a DPX-based immunotherapy that targets survivin-expressing cells that is Phase II clinical trials for diffuse large B cell lymphoma; ovarian cancer; and bladder, liver, and MSI-H solid tumors, as well as in Phase I clinical trial for breast cancer. It also develops DPX-SurMAGE that is in Phase I clinical trial for bladder cancer; and DPX-COVID-19 and DPX-RSV for infectious diseases. The company was formerly known as Immunovaccine Inc. and changed its name to IMV Inc. in May 2018. IMV Inc. was founded in 2000 and is headquartered in Dartmouth, Canada.Matinas Biopharma NYSEAMERICAN:MTNB$0.57 +0.01 (+1.44%) As of 05/14/2026 04:10 PM EasternMatinas BioPharma Holdings, Inc. is a clinical-stage biopharmaceutical company. It engages in the business of delivering groundbreaking therapies using lipid nanocrystal platform delivery technology to maximize global clinical impact and patient access. The company was founded by Herbert J. Conrad and Jerome D. Jabbour in May 2013 and is headquartered in Bedminster, NJ.Resverlogix TSE:RVXC$0.10 +0.01 (+5.26%) As of 05/14/2026 03:36 PM EasternResverlogix Corp clinical-stage biotechnology company. The company is developing an advanced epigenetic drug called apabetalone for the treatment of patients with cardiovascular disease, diabetes mellitus, chronic kidney disease, peripheral artery disease, orphan diseases, and neurodegenerative diseases. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas YETI Rallies After Earnings Beat and Raised Outlook Cisco’s Vertical Rally May Still Be in the Early Innings Dividend Growth or High Yield: The Income Investor's Bet Nebius Upside Expands as AI Feedback Loop Intensifies Oklo Stock Could Be Ready for Another Massive Run Amazon vs. Alibaba: One Is Clearly The Better Value Play right Now Insider Trades: Okta and Abbott See Buys, Micron Insiders Sell Qualcomm Stock Doubles: New Era? Or Another False Start? Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
